Abstract:Background In addition to deconditioning, persistent low-grade inflammation following acute SARS-CoV-2 infection may contribute to systemic problems, which supports the need for further assessment of cardiopulmonary conditioning. In fact, the impairment of the respiratory system in the acute phase of COVID-19 has the potential to significantly impact functional capacity in patients with post-COVID-19 syndrome (PCS), with dynamic hyperinflation (DH) and reduced ventilatory reserve (RV). Objective To investigate the dynamic ventilatory responses and their influence on the functional capacity to exercise in these patients. Methods Between March and October 2022, a cross-sectional study was carried out with 16 patients with PCS aged ≥18 years attended at the Piquet Carneiro Polyclinica, at the State University of Rio de Janeiro. Patients with a history of COVID-19 pneumonia with persistence of respiratory symptoms after 3 months of the acute phase were included. Patients without a previous diagnosis of COVID-19 confirmed by RT-PCR (reverse-transcription polymerase chain reaction) and those who failed to perform the protocol tests were excluded. Patients underwent impulse oscillometry (IOS), spirometry, 6-minute walk test (6MWT) with Spiropalm®-6MWT, and cardiopulmonary exercise test (CPET). A ≥100 ml decrease in inspiratory capacity (IC) during exercise was defined as HD. Ventilatory reserve (VR) indicates how close minute ventilation (VE) approaches maximum voluntary ventilation (MVV) during a given activity and was calculated as the difference between MVV and VEpeak ([MVV-VEpeak]/MVV); VR <30% was considered to be ventilatory limitation on exertion. Results Median age and time since diagnosis of COVID-19 were 57 (50–59) years and 98 (93–106) days, respectively. Regarding spirometry, 12.5% and 50% of the participants had an abnormal spirometry and an altered IOS, respectively, and the difference in resistance between 4 Hz and 20 Hz (R4-R20) was detected in 31.2% of the participants. cases. Regarding cardiopulmonary performance during exercise, the median distance in the 6MWT was 83 (78–97) % of predicted, with HD and VR <30% observed in 62.5% and 12.5% of participants, respectively. In CPET, the median peak oxygen consumption (VO2peak) was 19 (14–37) ml/kg/min. There was a significant correlation of the distance covered in the 6MWT with both R4-R20 (rs = -0.499, P = 0.039) and VO2peak (rs = 0.628, P = 0.009). Conclusion Our findings suggest that HD and, to a lesser extent, low VR are contributors to poor exercise performance that is associated with peripheral airway disease. Implications Based on these results, we obtained precise ventilatory and metabolic measurements, which we can consider as an important factor for more assertive exercise prescription during the rehabilitation of these patients. Moreover, these results are promising if we consider that they were obtained with simple, cheap, and portable ventilatory and metabolic measurement systems, easily applicable in real-world environments.

Hyperventilation as one of the mechanisms of persistent dyspnoea in SARS-CoV-2 survivors

Hyperventilation: A Possible Explanation for Long-Lasting Exercise Intolerance in Mild COVID-19 Survivors?

Functional respiratory complaints among COVID-19 survivors: a prospective cohort study

Unraveling persistent dyspnea after mild COVID: insights from a case series on hyperventilation provocation tests

Small Airways Dysfunction and Lung Hyperinflation in Long COVID-19 Patients as Potential Mechanisms of Persistent Dyspnoea

Exercise responses and mental health symptoms in COVID-19 survivors with dyspnoea

Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge

Ventilatory efficiency in long-term dyspnoeic patients following COVID-19 pneumonia

Cardiopulmonary exercise pattern in patients with persistent dyspnoea after recovery from COVID-19

Dyspnea and long COVID patients

Persistent pulmonary impairment after 2 years of COVID-19 infection: An observational study

Persistence of Diffusion Capacity Impairment and Its Relationship with Dyspnea 12 Months after Hospitalization for COVID-19

Bronchodilator response in Post-COVID-19 patients undergoing pulmonary rehabilitation

Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls

EVALUATION OF VENTILATION DURING EXERCISE TESTS IN PEOPLE WITH POST-COVID-19 SYNDROME

Residual symptoms and lower lung function in patients recovering from SARS-CoV-2 infection

Persistent disabilities 28 months after COVID-19 hospitalisation, a prospective cohort study

Cardiorespiratory dysautonomia in post-COVID-19 condition: Manifestations, mechanisms and management

Improved pulmonary function and exercise tolerance despite persistent pulmonary fibrosis over 1 year after severe COVID-19 infection

High incidence of hyperventilation syndrome after COVID-19

Dyspnea: The vanished warning symptom of COVID‐19 pneumonia